Literature DB >> 17055740

Formation of well-defined soluble aggregates upon fusion to MBP is a generic property of E6 proteins from various human papillomavirus species.

Katia Zanier1, Yves Nominé, Sebastian Charbonnier, Christine Ruhlmann, Patrick Schultz, Johannes Schweizer, Gilles Travé.   

Abstract

Protein aggregation is a main barrier hindering structural and functional studies of a number of interesting biological targets. The E6 oncoprotein of Human Papillomavirus strain 16 (E6(16)) is difficult to express under a native soluble form in bacteria. Produced as an unfused sequence, it forms inclusion bodies. Fused to the C-terminus of MBP, it is mainly produced in the form of soluble high molecular weight aggregates. Here, we produced as MBP-fusions seven E6 proteins from other HPV strains (5, 11, 18, 33, 45, 52, and 58) belonging to four different species, and we compared their aggregation state to that of MBP-E6(16). Using a fast mutagenesis method, we changed most non-conserved cysteines to the isosteric residue serine to minimize disulfide bridge-mediated aggregation during purification. Static and dynamic light scattering measurements, ultracentrifugation and electron microscopy demonstrated the presence in all MBP-E6 preparations of soluble high-molecular weight aggregates with a well-defined spherical shape. These aggregated particles are relatively monodisperse but their amount and their size vary depending on the conditions of expression and the strain considered. For all strains, minimal aggregate formation occurs when the expression is performed at 15 degrees C. Such observations suggest that the assembly of MBP-E6 aggregates takes place in vivo during protein biosynthesis, rather than occurring during purification. Finally, we show that all MBP-E6 preparations contain two zinc ions per protein monomer, suggesting that E6 domains within the high molecular weight aggregates possess a native-like fold, which enables correct coordination to the metal center.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055740     DOI: 10.1016/j.pep.2006.07.029

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  21 in total

Review 1.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

2.  Expression and Structural Analyses of Human DNA Polymerase θ (POLQ).

Authors:  Andrew W Malaby; Sara K Martin; Richard D Wood; Sylvie Doublié
Journal:  Methods Enzymol       Date:  2017-05-24       Impact factor: 1.600

3.  Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53.

Authors:  Katia Zanier; Abdellahi ould M'hamed ould Sidi; Charlotte Boulade-Ladame; Vladimir Rybin; Anne Chappelle; Andrew Atkinson; Bruno Kieffer; Gilles Travé
Journal:  Structure       Date:  2012-04-03       Impact factor: 5.006

4.  Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6.

Authors:  Abdellahi Ould M'hamed Ould Sidi; Khaled Ould Babah; Nicole Brimer; Yves Nominé; Christophe Romier; Bruno Kieffer; Scott Vande Pol; Gilles Travé; Katia Zanier
Journal:  Protein Expr Purif       Date:  2011-07-14       Impact factor: 1.650

5.  E6 proteins from diverse papillomaviruses self-associate both in vitro and in vivo.

Authors:  Katia Zanier; Christine Ruhlmann; Frederic Melin; Murielle Masson; Abdellahi Ould M'hamed Ould Sidi; Xavier Bernard; Benoit Fischer; Laurent Brino; Tutik Ristriani; Vladimir Rybin; Mireille Baltzinger; Scott Vande Pol; Petra Hellwig; Patrick Schultz; Gilles Travé
Journal:  J Mol Biol       Date:  2009-11-13       Impact factor: 5.469

6.  Identification of unusual E6 and E7 proteins within avian papillomaviruses: cellular localization, biophysical characterization, and phylogenetic analysis.

Authors:  Koenraad Van Doorslaer; Abdellahi Ould M'hamed Ould Sidi; Katia Zanier; Vladimir Rybin; François Deryckère; Annabel Rector; Robert D Burk; E Kurt Lienau; Marc van Ranst; Gilles Travé
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

7.  Enhancement of solubility in Escherichia coli and purification of an aminotransferase from Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B(1).

Authors:  Doris Hartinger; Stefan Heinl; Heidi Elisabeth Schwartz; Reingard Grabherr; Gerd Schatzmayr; Dietmar Haltrich; Wulf-Dieter Moll
Journal:  Microb Cell Fact       Date:  2010-08-18       Impact factor: 5.328

8.  Comparative production analysis of three phlebovirus nucleoproteins under denaturing or non-denaturing conditions for crystallographic studies.

Authors:  Violaine Lantez; Karen Dalle; Rémi Charrel; Cécile Baronti; Bruno Canard; Bruno Coutard
Journal:  PLoS Negl Trop Dis       Date:  2011-01-04

9.  Identification of soluble protein fragments by gene fragmentation and genetic selection.

Authors:  Michael R Dyson; Rajika L Perera; S Paul Shadbolt; Lynn Biderman; Krystyna Bromek; Natalia V Murzina; John McCafferty
Journal:  Nucleic Acids Res       Date:  2008-04-17       Impact factor: 16.971

10.  Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.

Authors:  Juan Ramirez; Juline Poirson; Clémence Foltz; Yassmine Chebaro; Maxime Schrapp; Amandine Meyer; Anaëlle Bonetta; Anne Forster; Yves Jacob; Murielle Masson; François Deryckère; Gilles Travé
Journal:  Angew Chem Int Ed Engl       Date:  2015-05-27       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.